Research study Program year 2020 Source: CMS Open Payments

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments

Research payments

$507,726

168 payments

Through program year 2020, $507,726 in research payments was reported against A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments, across 168 payments, paid by Teva Pharmaceuticals USA, Inc..

Paid by: Teva Pharmaceuticals USA, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$11,991	6
2019	Research	$495,735	162

Breakdown

Who paid Research payments · program years 2019–2020

Teva Pharmaceuticals USA, Inc. $507,726 168 payments

Who received the money Research payments · program years 2019–2020

Medvadis Research Corporation Organisation paid for research $111,258 9 payments
Dent Neurosciences Research Organisation paid for research $87,878 8 payments
David Kudrow Neurology · Santa Monica, CA $43,804 7 payments
Ki Health Partners LLC Organisation paid for research $35,522 12 payments
Clinical Research Institute Organisation paid for research $23,352 9 payments
Lewis Brandes AG Organisation paid for research $23,133 8 payments
Future Search Trials Of Neurology Organisation paid for research $22,698 10 payments
Albuquerque Clinical Trials Organisation paid for research $17,450 14 payments
Baptist Health Center for Clinical Research Organisation paid for research $15,704 10 payments
Artemis Institute For Clinical Research Organisation paid for research $15,392 7 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Cite this record

“A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments”, Who Paid My Doc, citing CMS Open Payments, program year 2020. https://www.whopaidmydoc.com/research-studies/a-multicenter-randomized-double-blind-parallel-group-placebo-controlled-study-with-an-open-label-period-to-evaluate-the-efficacy-and-safety-of-fremanezumab-for-the-prophylactic-treatment-of-migraine-in-patients-with-inadequate-response-to-prior-preventive-treatments-296481965

Figures here may be reproduced with attribution and a link — see for journalists and researchers.